DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026)

DBV Technologies (DBVT) reported Other Operating Expenses of $4.9 million for Q1 2026, up 1533.33% year-over-year from $300000.0 in Q1 2025, and up 259.5% quarter-over-quarter from $1.4 million in Q4 2025.

DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 7 years of Other Operating Expenses data on file, last reported at $4.9 million in Q1 2026.

  • Other Operating Expenses for Q1 2026 came in at $4.9 million, up 1533.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (up 257.06% YoY), and the FY2025 annual result was $3.2 million, up 21.17% from the prior year.
  • Other Operating Expenses improved to $4.9 million in Q1 2026 per DBVT's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $4.9 million in Q1 2026 and troughed at -$51000.0 in Q4 2022.
  • A 5-year average of $874352.9 and a median of $519000.0 in 2024 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 270.0% in 2022, then soared 1717.65% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at -$51000.0 in 2022, then soared by 1717.65% to $825000.0 in 2023, then slumped by 52.0% to $396000.0 in 2024, then surged by 244.19% to $1.4 million in 2025, then jumped by 259.5% to $4.9 million in 2026.
  • Business Quant data shows DBVT's Other Operating Expenses at $4.9 million in Q1 2026, $1.4 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.90 Mn
Dec 31, 2025 1.36 Mn
Sep 30, 2025 1.18 Mn
Jun 30, 2025 419,000.00
Mar 31, 2025 300,000.00
Dec 31, 2024 396,000.00
Sep 30, 2024 519,000.00
Jun 30, 2024 986,000.00
Mar 31, 2024 757,000.00
Dec 31, 2023 825,000.00
Sep 30, 2023 663,000.00
Jun 30, 2023 517,000.00
Mar 31, 2023 433,000.00
Dec 31, 2022 -51,000.00
Sep 30, 2022 159,000.00
Jun 30, 2022 1.04 Mn
Mar 31, 2022 464,000.00
Dec 31, 2021 30,000.00
Sep 30, 2021 1.07 Mn
Jun 30, 2021 1.20 Mn